The Griess assay: Suitable for a bio-guided fractionation of anti-inflammatory plant extracts?

被引:182
作者
Dirsch, VM
Stuppner, H
Vollmar, AM
机构
[1] Univ Munich, Inst Pharmakol Toxikol & Pharm, D-80539 Munich, Germany
[2] Univ Innsbruck, Inst Pharmakognosie, A-6020 Innsbruck, Austria
关键词
bio-assay; nitric oxide; Griess reaction; anti-inflammatory; plant extracts;
D O I
10.1055/s-2006-957473
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
In the field of inflammation research the inducible nitric oxide synthase (iNOS) became an important pharmacological target, since overproduction of nitric oxide (NO) after induction of this enzyme seems to be associated with numerous pathological conditions. NO released from cells can be detected and quantified photometrically as its stable product nitrite by a simple colorimetric reaction (Griess reaction). The aim of our study was to investigate whether this method might be suitable for the bio-guided fractionation of anti-inflammatory plant extracts. For this purpose we assayed extracts as well as fractions of the roots of Curcuma zanthorrhiza Roxb. which contain the known iNOS inhibitor curcumin, and compared the obtained activity with their curcumin content. Furthermore, leaf extracts of Betula pendula Roth, to which defined amounts of curcumin were added, were examined to clarify the question whether chlorophyll might interfere with the test system. The presented results suggest that the Griess assay is indeed suitable to guide fractionation of plant extracts in order to isolate highly active compounds. Factors, however, which might restrict the broad application of this assay are the limited selection of solvents which do not interfere with the system and high contents of chlorophyll in plant extracts.
引用
收藏
页码:423 / 426
页数:4
相关论文
共 11 条
[1]   CURCUMIN, AN ANTITUMOR PROMOTER AND ANTIINFLAMMATORY AGENT, INHIBITS INDUCTION OF NITRIC-OXIDE SYNTHASE IN ACTIVATED MACROPHAGES [J].
BROUET, I ;
OHSHIMA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (02) :533-540
[2]  
CATTELL V, 1995, HISTOCHEM J, V27, P777
[3]  
CLANCY RM, 1995, P SOC EXP BIOL MED, V210, P93
[4]  
Cochran FR, 1996, MED RES REV, V16, P547, DOI 10.1002/(SICI)1098-1128(199611)16:6<547::AID-MED3>3.3.CO
[5]  
2-W
[6]   The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages [J].
Dirsch, VM ;
Kiemer, AK ;
Wagner, H ;
Vollmar, AM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 336 (2-3) :211-217
[7]   Nitric oxide, a vital poison inside the immune and inflammatory network [J].
Dugas, B ;
Debre, P ;
Moncada, S .
RESEARCH IN IMMUNOLOGY, 1995, 146 (09) :664-670
[8]   ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS [J].
GREEN, LC ;
WAGNER, DA ;
GLOGOWSKI, J ;
SKIPPER, PL ;
WISHNOK, JS ;
TANNENBAUM, SR .
ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) :131-138
[9]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766
[10]   NITRIC-OXIDE AS A SECRETORY PRODUCT OF MAMMALIAN-CELLS [J].
NATHAN, C .
FASEB JOURNAL, 1992, 6 (12) :3051-3064